Compass Therapeutics, Inc. · NASDAQ:CMPX
BlackRock, Inc.'s stake in Compass Therapeutics, Inc. fell to 4.60% (Schedule 13G/A)
Event Jun 30, 2025 · Filed Jul 16, 2025
BlackRock, Inc.'s stake in Compass Therapeutics, Inc. fell to 4.60%, 6,398,988 shares, as a passive investor on Jun 30, 2025. Filed Jul 16, 2025 (Schedule 13G/A).
- Stake
- 4.60%
- Shares
- 6,398,988
- Intent
- Passive
- What changed
- Fell below 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| BlackRock, Inc. | 4.60% | 6,398,988 |
Source
Related
- Compass Therapeutics, Inc.
- BlackRock, Inc.
- Compass Therapeutics, Inc. shareholders
- Schedule 13G · BlackRock, Inc. · Jan 21, 2026
- Schedule 13G · BlackRock, Inc. · Feb 4, 2025
- Form 4 · Lerner Neil · Oct 2, 2026
- Form 4 · Lerner Neil · Sep 25, 2026
- Schedule 13G/A · Vivo Opportunity, LLC · Aug 14, 2026
- Schedule 13G · State Street Corp · Aug 7, 2026
- Schedule 13G/A · Biotechnology Value Fund L P · May 15, 2026